Keyphrases
Health Studies
100%
Lung Health
99%
Chronic Obstructive Pulmonary Disease
93%
Forced Expiratory Volume in 1 Second (FEV1)
57%
Smokers
56%
Lung Function
50%
Acute Exacerbation of COPD (AECOPD)
34%
Smoking Cessation
28%
Moderate to Severe
27%
Lung Function Decline
25%
Polymorphism
25%
Decline Rate
25%
Clinical Trials
24%
Partial Liquid Ventilation
20%
Confidence Interval
20%
Randomized Clinical Trial
18%
Placebo
17%
Intervention Studies
17%
Hospitalization
16%
Roux-en-Y Gastric Bypass
15%
Randomized Trial
15%
Medical Management
15%
Decline in Lung Function
15%
Multiple Risk Factor Intervention
14%
Usual Care
14%
Coronary Artery Disease
13%
FEV1 Decline
13%
Randomized Controlled Trial
13%
High Risk
12%
Visual Acuity
12%
Odds Ratio
12%
Advanced Glaucoma Intervention Study
11%
Ventilation
10%
Spirometry
10%
Smoking Cessation Intervention
10%
Pulmonary Function
10%
Smoking Intervention
10%
Cardiovascular Disease
10%
Gas Exchange
10%
Early Chronic Obstructive Pulmonary Disease
10%
Azithromycin
9%
Trabeculectomy
9%
Kidney Transplant Recipients
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Cardiovascular Mortality
9%
Generalized Estimating Equations
9%
Risk Factors
9%
Beta-blockers
9%
Lung
9%
Diabetes
8%
Medicine and Dentistry
Lung
88%
Chronic Obstructive Pulmonary Disease
63%
Smoking
43%
Nicotine Withdrawal
22%
Liquid Ventilation
18%
Roux-en-Y Gastric Bypass
15%
Randomized Controlled Trial
15%
Bronchodilating Agent
15%
Randomized Clinical Trial
14%
Clinical Trial
13%
Diabetes
13%
Placebo
13%
Surfactant
11%
Maturity Onset Diabetes of the Young
11%
Forced Expiratory Volume
11%
Gas Exchange
10%
Odds Ratio
9%
Glaucoma
9%
Gastric Bypass Surgery
9%
Airway Obstruction
8%
Gastric Bypass
8%
Lung Function
8%
Spirometry
8%
Cardiovascular Disease
8%
Intervention Study
8%
Stress Incontinence
8%
Drug Therapy
7%
Body Mass Index
7%
Methacholine
7%
Trabeculectomy
7%
Biopsy Technique
7%
Prevalence
7%
Intervention Trial
7%
Early Intervention
7%
Ischemic Heart Disease
6%
Visual Acuity
6%
Kidney Allograft
6%
Albinism
6%
Abstinence
6%
Incontinence
6%
Hemoglobin A1c
6%
Hazard Ratio
6%
Diabetes Mellitus
5%
Adverse Event
5%
Artificial Respiration
5%
Arm
5%
Lower Urinary Tract Symptom
5%
Urodynamics
5%
Human Immunodeficiency Virus
5%
Patient with Type 2 Diabetes
5%